BRK-B vs HSBC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
HSBC presents a contradictory profile, anchored by a weak Piotroski F-Score of 2/9 which indicates significant fundamental health concerns. While the stock shows explosive YoY revenue and earnings growth, this is offset by a poor earnings track record with an average surprise of -52.96% and a bearish technical trend (10/100). There is a massive valuation gap between the Graham Number ($41.8) and the growth-based Intrinsic Value ($177.0), suggesting the current price of $89.96 is speculative. Despite these risks, the dividend profile remains stable and the forward P/E is attractive.
Compare Another Pair
Related Comparisons
BRK-B vs HSBC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and HSBC Holdings plc (HSBC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.